Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Galderma R&D
Two groups randomized in a ratio of \[1:1\] for a 12-week period Five study evaluation were planned: at Baseline, week 2, Week 4, Week8 and Week12
Age
2–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female subject, aged 2 to 12 years inclusive
Controlled mild to moderate atopic dermatitis with a Investigator Global Assessment score at 0 or 1, within one week after successful treatment with topical corticosteroid.
You may not be if
Subject presenting bacterial, viral, fungal or parasite skin infection
Subject with ulcerated lesions, acne or rosacea
Immunosuppression
Subject with a wash-out period from baseline for topical treatment less than 8 days for Calcineurin inhibitor
Subject with a wash-out period from baseline for topical treatment more than 8 days for corticosteroid
Subject with a wash-out period from baseline for systemic treatment less than 8 days for anti-histamines, less than 4 weeks for immunomodulators